$SPFX
STANDARD PREMIUM FINANCE HOLDINGS, INC. Stock $spfx

$spfx Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000107997323000669 Filed on May 12, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$2.308M	$2.079M	$1.883M
YoY Change	12.99%	10.42%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$961.5K	$978.8K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.260K	$6.257K	$4.541K
YoY Change		37.79%
% of Gross Profit
Operating Expenses	$1.154M	$1.207M
YoY Change
Operating Profit
YoY Change
Interest Expense	$906.2K	$791.6K	$426.5K
YoY Change	86.91%	85.62%
% of Operating Profit
Other Income/Expense, Net	$35.58K	$27.47K	$43.84K
YoY Change	-23.03%	-37.34%
Pretax Income	$248.7K	$79.75K	$300.7K
YoY Change	-1.76%	-73.48%
Income Tax	$72.64K	$10.87K	$75.62K
% Of Pretax Income	29.21%	13.63%	25.15%
Net Earnings	$176.0K	$68.88K	$225.1K
YoY Change	-5.02%	-69.4%	24.86%
Net Earnings / Revenue	7.63%	3.31%	11.96%
Basic Earnings Per Share	$0.05	$0.01	$0.07
Diluted Earnings Per Share	$0.05	$0.01	$0.07
COMMON SHARES
Basic Shares Outstanding	2.905M shares	2.905M shares	2.905M shares
Diluted Shares Outstanding	3.246M shares	3.357M shares	2.905M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$147.8K	$260.5K
YoY Change
Cash & Equivalents	$147.8K	$260.5K	$106.9K
Short-Term Investments
Other Short-Term Assets	$393.7K	$349.8K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$56.32M	$52.63M
YoY Change	10.12%
LONG-TERM ASSETS
Property, Plant & Equipment	$98.42K	$97.33K
YoY Change	7.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$935.4K	$915.5K
YoY Change
Total Long-Term Assets	$1.219M	$1.230M
YoY Change	-2.18%
TOTAL ASSETS
Total Short-Term Assets	$56.32M	$52.63M
Total Long-Term Assets	$1.219M	$1.230M
Total Assets	$57.54M	$53.86M
YoY Change	9.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$1.583M	$1.564M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$40.89M	$37.00M
YoY Change
Long-Term Debt Due	$2.279M	$932.7K
YoY Change
Total Short-Term Liabilities	$44.76M	$39.49M
YoY Change	15.68%
LONG-TERM LIABILITIES
Long-Term Debt	$6.581M	$8.308M
YoY Change
Other Long-Term Liabilities	$48.87K	$57.91K
YoY Change
Total Long-Term Liabilities	$6.630M	$8.366M
YoY Change	-18.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$44.76M	$39.49M
Total Long-Term Liabilities	$6.630M	$8.366M
Total Liabilities	$51.39M	$47.86M
YoY Change	9.82%
SHAREHOLDERS EQUITY
Retained Earnings	$2.753M	$2.606M
YoY Change	23.75%
Common Stock	$2.905K	$2.905K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.153M	$5.999M	$4.768M
YoY Change
Total Liabilities & Shareholders Equity	$57.54M	$53.86M
YoY Change	9.83%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$176.0K	$68.88K	$225.1K
YoY Change	-5.02%	-69.4%	24.86%
Depreciation, Depletion And Amortization	$6.260K	$6.257K	$4.541K
YoY Change		37.79%
Cash From Operating Activities	$881.8K	$934.9K	$1.221M
YoY Change		-23.45%
INVESTING ACTIVITIES
Capital Expenditures	$7.350K	$0.00	$24.80K
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$3.923M	-$2.742M
YoY Change
Cash From Investing Activities	-$3.930M	-$2.742M	-$2.493M
YoY Change		10.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.936M	$1.647M	$1.358M
YoY Change		21.31%
NET CHANGE
Cash From Operating Activities	881.8K	$934.9K	$1.221M
Cash From Investing Activities	-3.930M	-$2.742M	-$2.493M
Cash From Financing Activities	2.936M	$1.647M	$1.358M
Net Change In Cash	-112.7K	-$160.7K	$85.90K
YoY Change		-287.1%
FREE CASH FLOW
Cash From Operating Activities	$881.8K	$934.9K	$1.221M
Capital Expenditures	$7.350K	$0.00	$24.80K
Free Cash Flow	$874.4K	$934.9K	$1.196M
YoY Change		-21.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001807893
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-56243
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 214
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33186
CY2023Q1	dei	City Area Code CityAreaCode	305
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	232-2752
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	STANDARD PREMIUM FINANCE HOLDINGS, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-2624094
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	13590 SW 134th Avenue
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	5946324	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2905016	shares
CY2023Q1	us-gaap	Cash Cash	260492	usd
CY2022Q4	us-gaap	Cash Cash	421211	usd
CY2023Q1	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	1148783	usd
CY2022Q1	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	1129498	usd
CY2023Q1	spfx	Premium Finance Contracts And Related Receivable Net PremiumFinanceContractsAndRelatedReceivableNet	52017743	usd
CY2022Q4	spfx	Premium Finance Contracts And Related Receivable Net PremiumFinanceContractsAndRelatedReceivableNet	49474903	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	349803	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	348795	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	52628038	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	50244909	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	97334	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	103591	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	168122	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	196407	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	48606	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	51920	usd
CY2023Q1	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	611467	usd
CY2022Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	603816	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	304000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	288164	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	915467	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	891980	usd
CY2023Q1	us-gaap	Assets Assets	53857567	usd
CY2022Q4	us-gaap	Assets Assets	51488807	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	34657905	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	32713625	usd
CY2023Q1	srt	Drafts Payable DraftsPayable	2337268	usd
CY2022Q4	srt	Drafts Payable DraftsPayable	1827884	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	755917	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1340597	usd
CY2023Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	72000	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	109000	usd
CY2023Q1	spfx	Payroll Protection Program Loan Current Portion PayrollProtectionProgramLoanCurrentPortion	92079	usd
CY2022Q4	spfx	Payroll Protection Program Loan Current Portion PayrollProtectionProgramLoanCurrentPortion	91852	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	110212	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	122554	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	12659	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	12494	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1454145	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1317699	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	39492185	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	37535705	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	6314004	usd
CY2023Q1	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	1856000	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	1816000	usd
CY2023Q1	spfx	Payroll Protection Program Loan Net Of Current Portion PayrollProtectionProgramLoanNetOfCurrentPortion	100814	usd
CY2022Q4	spfx	Payroll Protection Program Loan Net Of Current Portion PayrollProtectionProgramLoanNetOfCurrentPortion	123924	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	57910	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	73853	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	37332	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	40559	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	8366060	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	8000660	usd
CY2023Q1	us-gaap	Liabilities Liabilities	47858245	usd
CY2022Q4	us-gaap	Liabilities Liabilities	45536365	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2905016	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2905016	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2905016	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2905016	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	2905	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2905	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3390701	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3383651	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2605550	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2565720	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	5999322	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5952442	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	53857567	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51488807	usd
CY2023Q1	us-gaap	Revenues Revenues	2078804	usd
CY2022Q1	us-gaap	Revenues Revenues	1882596	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	791647	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	426490	usd
CY2023Q1	us-gaap	Salaries And Wages SalariesAndWages	429250	usd
CY2022Q1	us-gaap	Salaries And Wages SalariesAndWages	360699	usd
CY2023Q1	us-gaap	Leasing Commissions Expense LeasingCommissionsExpense	242435	usd
CY2022Q1	us-gaap	Leasing Commissions Expense LeasingCommissionsExpense	240849	usd
CY2023Q1	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	191853	usd
CY2022Q1	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	168105	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	87820	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	105802	usd
CY2023Q1	us-gaap	Postage Expense PostageExpense	27878	usd
CY2022Q1	us-gaap	Postage Expense PostageExpense	25366	usd
CY2023Q1	us-gaap	Other Expenses OtherExpenses	27474	usd
CY2022Q1	us-gaap	Other Expenses OtherExpenses	43844	usd
CY2023Q1	us-gaap	Other General Expense OtherGeneralExpense	200699	usd
CY2022Q1	us-gaap	Other General Expense OtherGeneralExpense	210753	usd
CY2023Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1999056	usd
CY2022Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1581908	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	79748	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	300688	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10868	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	75623	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	68880	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	225065	usd
CY2023Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	29050	usd
CY2022Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	17325	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	39830	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	207740	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2905016	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2905016	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3357414	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2905016	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	4534779	usd
CY2022Q1	spfx	Series A Convertible Preferred Stock Issued In Exchange For Note Payable SeriesAConvertiblePreferredStockIssuedInExchangeForNotePayable	20000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	5778	usd
CY2022Q1	spfx	Dividends Paid On Preferred Stock DividendsPaidOnPreferredStock	-17325	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	225065	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	4768297	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5952442	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	7050	usd
CY2023Q1	spfx	Dividends Paid On Preferred Stock DividendsPaidOnPreferredStock	-29050	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	68880	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	5999322	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	68880	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	225065	usd
CY2023Q1	us-gaap	Depreciation Depreciation	6257	usd
CY2022Q1	us-gaap	Depreciation Depreciation	4541	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-0	usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-2167	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	28285	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	25299	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	3314	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	3314	usd
CY2023Q1	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	191853	usd
CY2022Q1	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	168105	usd
CY2023Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-28519	usd
CY2022Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-21858	usd
CY2023Q1	spfx	Options Issued For Services OptionsIssuedForServices	7050	usd
CY2022Q1	spfx	Options Issued For Services OptionsIssuedForServices	5778	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1008	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-214001	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	15836	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	5000	usd
CY2023Q1	us-gaap	Increase Decrease In Book Overdrafts IncreaseDecreaseInBookOverdrafts	509384	usd
CY2022Q1	us-gaap	Increase Decrease In Book Overdrafts IncreaseDecreaseInBookOverdrafts	967902	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	136446	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-386541	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-28285	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-25299	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	934859	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1221190	usd
CY2023Q1	spfx	Disbursements Under Premium Finance Contracts Receivable Net DisbursementsUnderPremiumFinanceContractsReceivableNet	2734693	usd
CY2022Q1	spfx	Disbursements Under Premium Finance Contracts Receivable Net DisbursementsUnderPremiumFinanceContractsReceivableNet	2464921	usd
CY2023Q1	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	7651	usd
CY2022Q1	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	7587	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4500	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-0	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24800	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2742344	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2492808	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	0	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	-153264	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	1915761	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	1727314	usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	25000	usd
CY2022Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	200000	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	242000	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	215000	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	30000	usd
CY2022Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	27000	usd
CY2022Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	181302	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	3062	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	2906	usd
CY2023Q1	spfx	Repayment Of Ppp Loan RepaymentOfPppLoan	22883	usd
CY2022Q1	spfx	Repayment Of Ppp Loan RepaymentOfPppLoan	-0	usd
CY2023Q1	spfx	Dividends Paid On Series Convertible Preferred Stock DividendsPaidOnSeriesConvertiblePreferredStock	29050	usd
CY2022Q1	spfx	Dividends Paid On Series Convertible Preferred Stock DividendsPaidOnSeriesConvertiblePreferredStock	17325	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1646766	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1357517	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-160719	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	85899	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	421211	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20987	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	260492	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	106886	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	85000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	779684	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	423601	usd
CY2023Q1	spfx	Debt Exchanged For Series Convertible Preferred Stock DebtExchangedForSeriesConvertiblePreferredStock	0	usd
CY2022Q1	spfx	Debt Exchanged For Series Convertible Preferred Stock DebtExchangedForSeriesConvertiblePreferredStock	20000	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q1	spfx	Premium Finance Contracts Gross PremiumFinanceContractsGross	54324151	usd
CY2022Q4	spfx	Premium Finance Contracts Gross PremiumFinanceContractsGross	51525950	usd
CY2023Q1	us-gaap	Unearned Premiums UnearnedPremiums	75477791	usd
CY2022Q4	us-gaap	Unearned Premiums UnearnedPremiums	71315354	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate Increase Decrease DebtInstrumentInterestRateIncreaseDecrease	0.165	pure
CY2022Q1	us-gaap	Debt Instrument Interest Rate Increase Decrease DebtInstrumentInterestRateIncreaseDecrease	0.148	pure
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zqODwBMyYKsb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_866_zRuVGW1HVqme">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include assumptions used in valuation of deferred tax assets, allowance for doubtful accounts, depreciable lives of property and equipment, and valuation of stock-based compensation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p>
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zIoQnO1fwYK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86D_zhAX2WRoUyGa">Concentration of Credit and Financial Instrument Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash and loans receivable from customers, agents, and insurance companies. The Company maintains its cash balances at two banks. Accounts at these financial institutions are insured by the Federal Deposit Insurance Corporation up to $<span id="xdx_901_eus-gaap--CashFDICInsuredAmount_c20230331_pp0p0" title="FDIC insured amount">250,000</span>. Uninsured balances are $<span id="xdx_901_eus-gaap--CashUninsuredAmount_c20230331_pp0p0" title="Uninsured balances">316,404</span> and $<span id="xdx_900_eus-gaap--CashUninsuredAmount_c20221231_pp0p0" title="Uninsured balances">482,479</span> at March 31, 2023 and December 31, 2022, respectively. The Company mitigates this risk by maintaining its cash balances at high-quality financial institutions. The following table provides a reconciliation between uninsured balances and cash per the balance sheet:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--SchedulesOfReconciliationBetweenUninsuredBalancesAndCashTextBlock_zv8cKbyZWIIc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8B6_ztORJYbjfcnl" style="display: none">Schedule of reconciliation between uninsured balances and cash per the balance sheet</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20230331" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20221231" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt; text-align: justify"><span style="font-size: 8pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>March 31, 2023 <br/>(unaudited)</b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>December 31, 2022</b></span></td></tr> <tr id="xdx_402_eus-gaap--CashUninsuredAmount_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: justify">Uninsured Balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">316,404</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">482,479</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--PlusInsuredBalances_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Plus: Insured balances</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--PlusBalancesAtOtherInstitutionsThatDoNotExceedFdicLimit_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Plus: Balances at institutions that do not exceed FDIC limit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">136,984</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,758</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--OutstandingChecks_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Less: Outstanding checks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(442,896</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(329,026</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 11pt; text-align: justify; padding-bottom: 1pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--Cash_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Cash per Consolidated Balance Sheet</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">260,492</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">421,211</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company controls its credit risk in accounts receivable through credit standards, limits on exposure, by monitoring the financial condition of insurance companies, by adhering to statutory cancellation policies, and by monitoring and pursuing collections from past due accounts. We cancel policies at the earliest permissible date allowed by the statutory cancellation regulations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Approximately <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__srt--StatementGeographicalAxis__stpr--FL_zyBVFM7YSt52" title="Concentration risk percentage">59</span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__srt--StatementGeographicalAxis__stpr--FL_zYd2xoFDNk84" title="Concentration risk percentage">54</span>% of the Company’s business activity is with customers located in Florida for 2023 and 2022, respectively. Approximately <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__srt--StatementGeographicalAxis__stpr--GA_zGbp3BrWPIid" title="Concentration risk percentage">12</span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__srt--StatementGeographicalAxis__stpr--GA_zpY4rIUdxZ28" title="Concentration risk percentage">16</span>% of the Company’s business activity is with customers located in Georgia for 2023 and 2022, respectively. Approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__srt--StatementGeographicalAxis__stpr--NC_z6qL5Jg1ykX2" title="Concentration risk percentage">12</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__srt--StatementGeographicalAxis__stpr--NC_zkWGAOimgKDe" title="Concentration risk percentage">14</span>% of the Company's business activity is with customers located in North Carolina for 2023 and 2022, respectively. There were no other significant regional, industrial or group concentrations during the three months ended March 31, 2023 and 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	316404	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	482479	usd
CY2023Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	316404	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	482479	usd
CY2023Q1	spfx	Plus Insured Balances PlusInsuredBalances	250000	usd
CY2022Q4	spfx	Plus Insured Balances PlusInsuredBalances	250000	usd
CY2023Q1	spfx	Plus Balances At Other Institutions That Do Not Exceed Fdic Limit PlusBalancesAtOtherInstitutionsThatDoNotExceedFdicLimit	136984	usd
CY2022Q4	spfx	Plus Balances At Other Institutions That Do Not Exceed Fdic Limit PlusBalancesAtOtherInstitutionsThatDoNotExceedFdicLimit	17758	usd
CY2023Q1	spfx	Outstanding Checks OutstandingChecks	-442896	usd
CY2022Q4	spfx	Outstanding Checks OutstandingChecks	-329026	usd
CY2023Q1	us-gaap	Cash Cash	260492	usd
CY2022Q4	us-gaap	Cash Cash	421211	usd
CY2023Q1	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	611467	usd
CY2022Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	603816	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q1	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	207400	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	187400	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	187400	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1035000	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	975000	shares
CY2023Q1	spfx	Insurance Premium Finance Contracts Outstanding InsurancePremiumFinanceContractsOutstanding	49019805	usd
CY2022Q4	spfx	Insurance Premium Finance Contracts Outstanding InsurancePremiumFinanceContractsOutstanding	45520349	usd
CY2023Q1	spfx	Insurance Premium Finance Contracts Cancelled InsurancePremiumFinanceContractsCancelled	5304346	usd
CY2022Q4	spfx	Insurance Premium Finance Contracts Cancelled InsurancePremiumFinanceContractsCancelled	6005601	usd
CY2023Q1	spfx	Insurance Premium Finance Contracts Gross InsurancePremiumFinanceContractsGross	54324151	usd
CY2022Q4	spfx	Insurance Premium Finance Contracts Gross InsurancePremiumFinanceContractsGross	51525950	usd
CY2023Q1	spfx	Amounts Due From Agents AmountsDueFromAgents	687279	usd
CY2022Q4	spfx	Amounts Due From Agents AmountsDueFromAgents	645648	usd
CY2023Q1	spfx	Unearned Interest UnearnedInterest	-1844904	usd
CY2022Q4	spfx	Unearned Interest UnearnedInterest	-1567197	usd
CY2023Q1	spfx	Insurance Premium Finance Contracts Net InsurancePremiumFinanceContractsNet	53166526	usd
CY2022Q4	spfx	Insurance Premium Finance Contracts Net InsurancePremiumFinanceContractsNet	50604401	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1148783	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1129498	usd
CY2023Q1	spfx	Premium Finance Contracts And Related Receivable Net PremiumFinanceContractsAndRelatedReceivableNet	52017743	usd
CY2022Q4	spfx	Premium Finance Contracts And Related Receivable Net PremiumFinanceContractsAndRelatedReceivableNet	49474903	usd
CY2023Q1	spfx	Allowance For Premium Finance Contracts AllowanceForPremiumFinanceContracts	1016347	usd
CY2022Q4	spfx	Allowance For Premium Finance Contracts AllowanceForPremiumFinanceContracts	1000000	usd
CY2023Q1	spfx	Allowance For Amounts Due From Agents AllowanceForAmountsDueFromAgents	132436	usd
CY2022Q4	spfx	Allowance For Amounts Due From Agents AllowanceForAmountsDueFromAgents	129498	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1148783	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1129498	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1129498	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1193757	usd
CY2023Q1	spfx	Current Year Additions To Allowance CurrentYearAdditionsToAllowance	366000	usd
CY2022	spfx	Current Year Additions To Allowance CurrentYearAdditionsToAllowance	1347475	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	377630	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1513814	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	30915	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	102080	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1148783	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1129498	usd
CY2023Q1	spfx	Current Additions To Allowance CurrentAdditionsToAllowance	366000	usd
CY2022Q1	spfx	Current Additions To Allowance CurrentAdditionsToAllowance	335000	usd
CY2023Q1	spfx	Contra Rrevenues ContraRrevenues	174147	usd
CY2022Q1	spfx	Contra Rrevenues ContraRrevenues	166895	usd
CY2023Q1	spfx	Provision For Credit Losses ProvisionForCreditLosses	191853	usd
CY2022Q1	spfx	Provision For Credit Losses ProvisionForCreditLosses	168105	usd
CY2023Q1	spfx	Premium Finance Contracts Outstanding PremiumFinanceContractsOutstanding	49019805	usd
CY2023Q1	spfx	Premium Finance Contracts Cancelled PremiumFinanceContractsCancelled	5304346	usd
CY2023Q1	spfx	Premium Finance Contracts Gross PremiumFinanceContractsGross	54324151	usd
CY2022Q4	spfx	Premium Finance Contracts Outstanding PremiumFinanceContractsOutstanding	45520349	usd
CY2022Q4	spfx	Premium Finance Contracts Cancelled PremiumFinanceContractsCancelled	6005601	usd
CY2022Q4	spfx	Premium Finance Contracts Gross PremiumFinanceContractsGross	51525950	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	49991	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	53053	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y2M23D
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	348399	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	348399	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	251065	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	244808	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	97334	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	103591	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6257	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4541	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	168122	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	196407	usd
CY2023Q1	spfx	Server Lease ServerLease	48606	usd
CY2022Q4	spfx	Server Lease ServerLease	51920	usd
CY2023Q1	spfx	Total Lease Assets TotalLeaseAssets	216728	usd
CY2022Q4	spfx	Total Lease Assets TotalLeaseAssets	248327	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	110212	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	122554	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	57910	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	73853	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	168122	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	196407	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	12659	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	12494	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	37332	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	40559	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y4M24D
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	30056	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	28193	usd
CY2023Q1	srt	Drafts Payable DraftsPayable	2337268	usd
CY2022Q4	srt	Drafts Payable DraftsPayable	1827884	usd
CY2022Q4	us-gaap	Line Of Credit Facility Collateral Fees Amount LineOfCreditFacilityCollateralFeesAmount	25771	usd
CY2022Q4	us-gaap	Line Of Credit Facility Collateral Fees Amount LineOfCreditFacilityCollateralFeesAmount	117228	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	7801	usd
CY2023Q1	us-gaap	Other Notes Payable OtherNotesPayable	192893	usd
CY2022Q4	us-gaap	Other Notes Payable OtherNotesPayable	215776	usd
CY2023Q1	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	92079	usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	91852	usd
CY2023Q1	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	100814	usd
CY2022Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	123924	usd
CY2023Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	128000	usd
CY2022Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	128000	usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	25000	usd
CY2022Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	200000	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	242000	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	215000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	250000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	25000	shares
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	10.00
CY2023Q1	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	1928000	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	1925000	usd
CY2023Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	72000	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	109000	usd
CY2023Q1	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	1856000	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	1816000	usd
CY2023Q1	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	39000	usd
CY2022Q1	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	39000	usd
CY2023Q1	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	30000	usd
CY2022Q1	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	0	usd
CY2023Q1	spfx	Repayments Of Other Notes Payable RepaymentsOfOtherNotesPayable	27000	usd
CY2022Q1	spfx	Repayments Of Other Notes Payable RepaymentsOfOtherNotesPayable	181302	usd
CY2022Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	10.00
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	spfx	Designated Shares DesignatedShares	600000	shares
CY2022Q4	spfx	Designated Shares DesignatedShares	600000	shares
CY2023Q1	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	10
CY2023Q1	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	1689050	usd
CY2023Q1	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	10
CY2023Q1	us-gaap	Dividends Dividends	29050	usd
CY2022Q1	us-gaap	Dividends Dividends	17325	usd
CY2023Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	29050	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	17558	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2905016	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2905016	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2905016	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2905016	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	207400	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y10M24D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.18
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	187400	shares
CY2023Q1	spfx	Sharesbased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y11M1D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.80
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	207400	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.18
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P7Y1M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1091236	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	0	shares
CY2022Q1	spfx	Weighted Average Exercise Price Options Issued WeightedAverageExercisePriceOptionsIssued	0
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	207400	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.18
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P6Y10M24D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1362930	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	187400	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.80
CY2023Q1	spfx	Sharesbased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y11M1D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1302430	usd
CY2023Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	7050	usd
CY2022Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	5778	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1035000	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.09
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P2Y7M6D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	1549400	usd
CY2023Q1	spfx	Warrants Issued WarrantsIssued	0	shares
CY2023Q1	spfx	Weighted Average Exercise Price Issued WeightedAverageExercisePriceIssued	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0	shares
CY2023Q1	spfx	Share Based Compensation Arrangements By Share Based Payment Award Other Than Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1035000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.09
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P2Y3M29D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	2381250	usd
CY2023Q1	spfx	Warrants Exercisable WarrantsExercisable	1035000	shares
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	7.09
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P2Y3M29D
CY2023Q1	spfx	Sharebased Compensation Arrangement By Sharebased Payment Award Otherthan Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOtherthanOptionsExercisableIntrinsicValue1	2381250	usd
CY2022Q2	spfx	Warrant Issued For Services WarrantIssuedForServices	10800	usd
CY2021Q2	spfx	Warrant Issued For Services WarrantIssuedForServices	9275	usd
CY2020Q2	spfx	Warrant Issued For Services WarrantIssuedForServices	27200	usd
CY2023Q1	spfx	Stock Warrant Expense StockWarrantExpense	0	usd
CY2022Q1	spfx	Stock Warrant Expense StockWarrantExpense	0	usd
CY2023Q1	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2025-11-30
CY2023Q1	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	1928000	usd
CY2022Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	1925000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001079973-23-000669-index-headers.html	Edgar Link	pending
0001079973-23-000669-index.html	Edgar Link	pending
0001079973-23-000669.txt	Edgar Link	pending
0001079973-23-000669-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
spfx-20230331.xsd	Edgar Link	pending
spfx_10q-033123.htm	Edgar Link	pending
spfx_ex31x1.htm	Edgar Link	pending
spfx_ex31x2.htm	Edgar Link	pending
spfx_ex32x1.htm	Edgar Link	pending
spfx-20230331_def.xml	Edgar Link	unprocessable
spfx-20230331_cal.xml	Edgar Link	unprocessable
spfx-20230331_lab.xml	Edgar Link	unprocessable
spfx-20230331_pre.xml	Edgar Link	unprocessable
spfx_10q-033123_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SPFX
STANDARD PREMIUM FINANCE HOLDINGS, INC. Stock $spfx

2023 Q2 Form 10-Q Financial Statement

#000107997323000669 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SPFX STANDARD PREMIUM FINANCE HOLDINGS, INC. Stock $spfx

2023 Q2 Form 10-Q Financial Statement

#000107997323000669 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SPFX
STANDARD PREMIUM FINANCE HOLDINGS, INC. Stock $spfx